Literature DB >> 31020135

Giant right atrial thrombus associated with ICD lead externalized conductors: a case report.

Jean-Benoît le Polain de Waroux1, Christophe Scavée1, Sébastien Marchandise1.   

Abstract

INTRODUCTION: Narrow calibre ICD leads are prone to present insulation defects and conductor externalization. Close follow-up of these leads is recommended but as long as their electrical function is maintained, no prophyllactic replacement or extraction is advised. Although the risk of thrombus formation involving externalized conductors has been described, this risk seems considered as negligible compared with the risk of a prophylactic lead extraction. However, when an intracavitar thrombus is identified, the safest therapeutic approach remains undetermined. CASE
PRESENTATION: In the present clinical vignette, we describe the case of a giant thrombus developed along the externalized portion of an electrically functional ICD lead. In this case, the thrombus was successfully treated with a systemic oral anticoagulation. DISCUSSION: This case report supports the concept of a prolonged anticoagulation for both the diagnosis and the long-term treatment of thrombus developed along externalized ICD leads, in particular when the patient prefers to avoid or postpone the risk of a trans-venous lead extraction.

Entities:  

Keywords:  Case report; Conductor externalization; ICD; Insulation failure; Riata lead; Thrombosis

Year:  2018        PMID: 31020135      PMCID: PMC6176969          DOI: 10.1093/ehjcr/yty056

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


ICD conductor extrusion can be associated with an increased risk of intracavitary thrombus formation. In such situation, systemic oral anticoagulation can be helpful for both the diagnostic and treatment of the patient. Individual patient profile and wishes should guide the long-term therapy.

Introduction

Narrow calibre ICD leads have been recalled due to increased risk of insulation failure and cable extrusions. Regular fluoroscopic screening of these leads is recommended. But, as long as they remain electrically functional, no prophylactic replacement or extraction is advised. However, when an intracavitar thrombus involving externalized conductors is identified, the safest therapeutic approach remains undetermined.

Case presentation

A 45-year-old Caucasian man suffering from arythmogenic right ventricular dysplasia, and implanted 8 years earlier with a Saint Jude Medical Riata lead, presented to our emergency department after he received an appropriate therapy for a prolonged episode of slow VT. During his last follow-up (3 months before), an externalization of the conductors at the distal part of the ICD lead was diagnosed, but, the ICD lead remaining electrically functional, the patient was reassured. During his stay at the emergency, the physical exam was normal but a transthoracic echocardiography was performed and identified an endocavitary mass appended to the ICD lead. A 3-dimensional transoesophageal echocardiography confirmed the presence of a large irregular right atrial mass (3 × 2 cm) attached to the ICD lead in the right atrium (Figure and Supplementary material online, ), precisely where the fluoroscopic investigation identified the conductor externalization (Figure , arrows). The CRP being normal, the primary hypothesis was an endocavitary thrombus and the patient was therefore anticoagulated. After 2 months of treatment with acenocoumarol (Target INR = 3), the atrial mass had completely disappeared, confirming thus the suspected diagnosis. At this stage, the patient was proposed for a transvenous lead extraction with reimplantation of a new high voltage lead. However, he declined and opted for a prolonged anticoagulation. At his last follow-up, 9 months after discharge, an echocardiography was performed, confirming the absence of thrombus recurrence. A 3-dimensional transoesophageal echocardiography showing a large thrombus attached along the ICD lead in the right atrium, precisely where fluoroscopic investigation identified the conductor externalization (see Figure ). Antero-posterior fluoroscopic examination of the riata lead demonstrating a clear conductor externalization (arrows) in the right atrium.

Discussion

Although narrow calibre ICD leads with insulation defects and conductor externalization are presumed to increase the thrombogenic risk, very few reports were published to document this specific problem., In our opinion, this risk should be taken into account in the clinical decision making process to explant or abandon ICD leads with insulation failure. In this case, the ICD lead remaining electrically functional, our patient opted for a long-term anticoagulation. Although it might be suggested that a lead extraction would have been a more definite solution with only a limited risk if performed in experienced centres, the risk of thrombus still exists, even with non-advisory leads. Therefore, we believe that individual patient profile and wishes should guide the therapy.

Supplementary material

Supplementary material is available at European Heart Journal - Case Reports online. Consent: The author/s confirm that written consent for submission and publication of this case report including image(s) and associated text has been obtained from the patient in line with COPE guidance. Conflict of interest: none declared. Click here for additional data file.
Events
2008Reanimated of sudden cardiac arrest— diagnostic: VT/VF
Primary cardiac disease: Arrhythmogenic right ventricular dysplasia
Implantation of SJM Riata lead
2015Several appropriate ICD therapy
Generator change due to battery depletion
November 2016Conductor externalization identified during routine ICD follow-up
January 2017Appropriate ICD therapy for VT
TEE/TEO identify a large intracavitary mass where the conductors are externalized
Oral AC is started
May 2017TEE check: atrial thrombus has disappeared
September 2017Recurrence of VT appropriately treated
Patient under OAC
No thrombus recurrence
  4 in total

1.  Multicenter experience with extraction of the Riata/Riata ST ICD lead.

Authors:  Melanie Maytin; Bruce L Wilkoff; Michael Brunner; Edmond Cronin; Charles J Love; Maria Grazia Bongiorni; Luca Segreti; Roger G Carrillo; Juan D Garisto; Steven Kutalek; Faiz Subzposh; Avi Fischer; James O Coffey; Sandeep R Gangireddy; Samir Saba; Suneet Mittal; Aysha Arshad; Ryan Michael O'Keefe; Charles A Henrikson; Peter Belott; Roy M John; Laurence M Epstein
Journal:  Heart Rhythm       Date:  2014-05-20       Impact factor: 6.343

2.  A case of in vivo thrombogenicity of an externalized Riata ST lead.

Authors:  Danilo Ricciardi; Mark La Meir; Carlo de Asmundis; Pedro Brugada
Journal:  Europace       Date:  2013-03       Impact factor: 5.214

Review 3.  2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.

Authors:  Fred M Kusumoto; Mark H Schoenfeld; Bruce L Wilkoff; Charles I Berul; Ulrika M Birgersdotter-Green; Roger Carrillo; Yong-Mei Cha; Jude Clancy; Jean-Claude Deharo; Kenneth A Ellenbogen; Derek Exner; Ayman A Hussein; Charles Kennergren; Andrew Krahn; Richard Lee; Charles J Love; Ruth A Madden; Hector Alfredo Mazzetti; JoEllyn Carol Moore; Jeffrey Parsonnet; Kristen K Patton; Marc A Rozner; Kimberly A Selzman; Morio Shoda; Komandoor Srivathsan; Neil F Strathmore; Charles D Swerdlow; Christine Tompkins; Oussama Wazni
Journal:  Heart Rhythm       Date:  2017-09-15       Impact factor: 6.343

4.  Lead thrombi associated with externalized cables on Riata ICD leads: a case series.

Authors:  Sandeep K Goyal; Christopher R Ellis; Jeffery N Rottman; S Patrick Whalen
Journal:  J Cardiovasc Electrophysiol       Date:  2013-04-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.